Tilray Inc. (NASDAQ: TLRY) released third-quarter financial results after the closing bell on Tuesday. The company said that it had a net loss of $0.50 per share and $51.1 million in revenue, compared with consensus estimates that called for a net loss of $0.29 per share and $49.41 million in revenue. The same period from last year had a net loss of $0.20 per share and $10.05 million in revenue.
Overall, revenues increased 408.6% year over year, driven by the Canadian adult-use market, the Manitoba Harvest acquisition, and growth in international medical markets as a result of the first GMP certification of the Portugal facility.
Total kilogram equivalents sold increased over six-fold to 10,848 kilograms from 1,613 kilograms in the prior-year period.
The average net selling price per gram decreased to $3.25 compared to $6.21 in the prior-year period. The average net selling price excluding excise taxes for adult-use was $2.98 per gram for the third quarter of 2019. The decrease was due to a shift in product and channel mix.
Brendan Kennedy, Tilray’s president and CEO, commented:
Our performance in the third quarter, including solid revenue growth and sequential gross margin expansion, reflects the positive business trends we have underway. We are in the early days of seeing our strategic initiatives bear fruit – including our European expansion, brand portfolio evolution and strategic partnership product launches. We continue to expect significant growth in the fourth quarter and into 2020.
Shares of Tilray closed Tuesday at $21.57, with a 52-week range of $20.20 to $120.40. The consensus analyst price target is $37.00. Following the announcement, the stock was initially up 2% at $22.00 in the after-hours session.
Smart Investors Are Quietly Loading Up on These “Dividend Legends”
If you want your portfolio to pay you cash like clockwork, it’s time to stop blindly following conventional wisdom like relying on Dividend Aristocrats. There’s a better option, and we want to show you. We’re offering a brand-new report on 2 stocks we believe offer the rare combination of a high dividend yield and significant stock appreciation upside. If you’re tired of feeling one step behind in this market, this free report is a must-read for you.
Click here to download your FREE copy of “2 Dividend Legends to Hold Forever” and start improving your portfolio today.
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.
Editors' Picks
